• Contáctenos 3213428582 Línea directa: 60-1-2130025
Logo Editorial Medica CELSUS
IR A LA BÚSQUEDA AVANZADA
  • Mi cesta
  • Buscar
  • Mi cesta
IR A LA BÚSQUEDA AVANZADA
Medicina

Atlas Of Dermatopathology Synopsis And Atlas Of Lever'S Histopathology Of The Skin 4Ed

Atlas Of Dermatopathology Synopsis And Atlas Of Lever'S Histopathology Of The Skin 4Ed
    Información general
  • Formato Impreso
  • Acabado Tapa Dura
  • Año de publicación 2020
  • Editorial Wolters Kluwer Inglés
  • Autor ELDER
  • Páginas 584
  • ISBN 9781975124632
  • Edición 4ª Edición
  • Precio Lista USD $ 190
  • Precio Lista USD $ 190
  • Precio CELSUS USD $ 171
Cotizar
Añadir a la Lista de Deseos Añadir para comparar

  1. Cover
  2. Title Page
  3. Copyright
  4. Brief Contents
  5. How to Use This Book
  6. Detailed Contents
  7. Preface
  8. Preface to the First Edition
  9. Acknowledgments
  10. Introduction
  11. Disorders Mostly Limited to the Epidermis and Stratum Corneum
  12. IA HYPERKERATOSIS WITH HYPOGRANULOSIS
  13. IA1 No Inflammation
  14. Ichthyosis Vulgaris
  15. IB HYPERKERATOSIS WITH NORMAL OR HYPERGRANULOSIS
  16. IB1 No Inflammation
  17. X-Linked Ichthyosis
  18. Epidermolytic Hyperkeratosis
  19. Epidermodysplasia Verruciformis
  20. IB2 Scant Inflammation
  21. Lichen Amyloidosis and Macular Amyloidosis
  22. IC HYPERKERATOSIS WITH PARAKERATOSIS
  23. IC1 Scant or No Inflammation
  24. Dermatophytosis
  25. Granular Parakeratosis
  26. ID LOCALIZED OR DIFFUSE HYPERPIGMENTATIONS
  27. ID1 No Inflammation
  28. Mucosal Melanotic Macules (Mucosal Lentigines)
  29. Ephelids (Freckles)
  30. ID2 Scant Inflammation
  31. Pityriasis (Tinea) Versicolor
  32. IE LOCALIZED OR DIFFUSE HYPOPIGMENTATIONS
  33. IE1 With or Without Slight Inflammation
  34. Vitiligo
  35. References
  36. Localized Superficial Epidermal or Melanocytic Proliferations
  37. IIA Localized Irregular Thickening of the Epidermis
  38. IIA1 Localized Epidermal Proliferations
  39. Actinic Keratosis
  40. Eccrine Poroma
  41. Squamous Cell Carcinoma In Situ and Bowen Disease
  42. Bowenoid Papulosis
  43. Clear Cell Squamous Cell Carcinoma In Situ
  44. Clear Cell Acanthoma
  45. IIA2 Superficial Melanocytic Proliferations
  46. Superficial Melanocytic Nevi and Melanomas
  47. Pigmented Spindle Cell Nevus
  48. Acral Melanoma
  49. IIB Localized Lesions With Thinning of the Epidermis
  50. IIB1 With Melanocytic Proliferation
  51. Lentigo Maligna Melanoma, In Situ or Microinvasive (High CSD)
  52. Recurrent (“Persistent”) Nevus, Lentiginous Patterns
  53. Superficial Atypical Melanocytic Proliferations of Uncertain Significance (SAMPUS and IAMPUS), Lentiginous Patterns
  54. IIB2 Without Melanocytic Proliferation
  55. Atrophic Actinic Keratosis
  56. Porokeratosis
  57. IIC Localized Lesions With Elongated Rete Ridges
  58. IIC1 With Melanocytic Proliferation
  59. Actinic Lentigo
  60. Lentigo Simplex
  61. Lentiginous Junctional Nevus
  62. Nevus Spilus
  63. Junctional or Superficial Compound Dysplastic Nevi
  64. Nevoid Lentigo Maligna
  65. IIC2 Without Melanocytic Proliferation
  66. Epidermal Nevus
  67. Seborrheic Keratoses
  68. Acanthosis Nigricans
  69. IID Localized Lesions With Pagetoid Epithelial Proliferation
  70. IID1 Keratinocytic Proliferations
  71. Pagetoid Squamous Cell Carcinoma In Situ (Bowen Disease)
  72. Clonal Seborrheic Keratosis
  73. IID2 Melanocytic Proliferation
  74. Melanoma In Situ or Microinvasive, Superficial Spreading Type
  75. Recurrent Nevus (Pseudomelanoma), Pagetoid Pattern
  76. Junctional Spitz Tumor (Nevus) With Pagetoid Proliferation
  77. Superficial/Intraepidermal Atypical Melanocytic Proliferations of Uncertain Significance (SAMPUS/IAMPUS), Pagetoid Patterns
  78. IID3 Glandular Epithelial Proliferations
  79. Paget Disease
  80. IID4 Lymphoid Proliferations
  81. Pagetoid Reticulosis (Woringer–Kolopp Disease)
  82. IIE Localized Papillomatous Epithelial Lesions
  83. IIE1 With Viral Cytopathic Effects
  84. Verruca Vulgaris
  85. Verruca Plana
  86. Deep Palmoplantar Warts (Myrmecia)
  87. Condyloma Acuminatum
  88. Molluscum Contagiosum
  89. Parapox Virus Infections (Milkers’ Nodules, Orf)
  90. IIE2 No Viral Cytopathic Effect
  91. Seborrheic Keratosis
  92. Dowling–Degos Disease
  93. Confluent and Reticulated Papillomatosis (Gougerot–Carteaud)
  94. Verrucous Melanoma
  95. IIF Irregular Proliferations Extending Into the Superficial Dermis
  96. IIF1 Squamous Differentiation
  97. Inverted Follicular Keratosis
  98. IIF2 Basaloid Differentiation
  99. Basal Cell Carcinoma
  100. IIG Superficial Polypoid Lesions
  101. IIG1 Melanocytic Lesions
  102. Polypoid Dermal and Compound Nevi
  103. IIG2 Spindle Cell and Stromal Lesions
  104. Neurofibroma
  105. Fibroepithelial Polyp
  106. References
  107. Disorders of the Superficial Cutaneous Reactive Unit
  108. IIIA Superficial Perivascular Dermatitis
  109. IIIA1 Superficial Perivascular Dermatitis, Mostly Lymphocytes
  110. Viral Exanthem
  111. Pityriasis Versicolor
  112. Lupus Erythematosus, Acute
  113. Small Plaque Parapsoriasis (Guttate Parapsoriasis)
  114. IIIA1a Superficial Perivascular Dermatitis With Eosinophils
  115. Morbilliform Drug Eruption
  116. Urticaria
  117. Urticarial Bullous Pemphigoid
  118. IIIA1b Superficial Perivascular Dermatitis With Neutrophils
  119. Erysipelas
  120. Erysipelas/Cellulitis
  121. IIIA1c Superficial Perivascular Dermatitis With Plasma Cells
  122. Secondary Syphilis
  123. Kaposi Sarcoma, Patch Stage
  124. IIIA1d Superficial Perivascular Dermatitis, With Extravasated Red Cells
  125. Pityriasis Rosea
  126. Pityriasis Lichenoides
  127. Pigmented Purpuric Dermatosis
  128. IIIA1e Superficial Perivascular Dermatitis, Melanophages Prominent
  129. Postinflammatory Hyperpigmentation
  130. IIIA2 Superficial Perivascular Dermatitis, Mast Cells Predominant
  131. Urticaria Pigmentosa
  132. IIIB Superficial Dermatitis With Spongiosis (Spongiotic Dermatitis)
  133. Acute Spongiotic Dermatitis
  134. Subacute Spongiotic Dermatitis
  135. Chronic Spongiotic Dermatitis
  136. IIIB1 Spongiotic Dermatitis, Lymphocytes Predominant
  137. Nummular Dermatitis (Eczema)
  138. Meyerson Nevus
  139. IIIB1a Spongiotic Dermatitis, With Eosinophils
  140. Allergic Contact Dermatitis
  141. Allergic Contact Dermatitis
  142. IIIB1b Spongiotic Dermatitis, With Plasma Cells
  143. IIIB1c Spongiotic Dermatitis, With Neutrophils
  144. Seborrheic Dermatitis
  145. IIIC Superficial Dermatitis With Epidermal Atrophy (Atrophic Dermatitis)
  146. IIIC1 Atrophic Dermatitis, Scant Inflammatory Infiltrates
  147. Aged Skin
  148. Chronic Radiation Dermatitis
  149. IIIC2 Atrophic Dermatitis, Lymphocytes Predominant
  150. Poikiloderma Atrophicans Vasculare
  151. Dermatomyositis
  152. IIIC3 Atrophic Dermatitis With Papillary Dermal Sclerosis
  153. Lichen Sclerosus Et Atrophicus
  154. IIID Superficial Dermatitis With Psoriasiform Proliferation (Psoriasiform Dermatitis)
  155. IIID1 Psoriasiform Dermatitis, Mostly Lymphocytes
  156. Pityriasis Rubra Pilaris
  157. Mycosis Fungoides, Patch-Plaque Stage
  158. Parapsoriasis
  159. IIID1a Psoriasiform Dermatitis, With Plasma Cells
  160. Lichen Simplex Chronicus (See also IIIE)
  161. IIID1b Psoriasiform Dermatitis, With Eosinophils
  162. Chronic Spongiotic Dermatitis
  163. IIID2 Psoriasiform Dermatitis, Neutrophils Prominent (Neutrophilic/Pustular Psoriasiform Dermatitis)
  164. Psoriasis Vulgaris
  165. Guttate Psoriasis
  166. IIID3 Psoriasiform Dermatitis, With Epidermal Pallor and Necrosis (“Nutritional Pattern” Dermatoses)
  167. Necrolytic Migratory Erythema (Glucagonoma Syndrome)
  168. Necrolytic Acral Erythema
  169. Pellagra
  170. IIIE Superficial Dermatitis With Irregular Epidermal Proliferation (“Hypertrophic Dermatitis”)
  171. IIIE1 Hypertrophic Dermatitis, Lymphocytes Predominant
  172. Prurigo Nodularis
  173. IIIE1a Irregular Epidermal Proliferation, Plasma Cells Present
  174. Actinic Keratosis (See also IIA1)
  175. IIIE2 Irregular Epidermal Proliferation, Neutrophils Prominent
  176. Keratoacanthoma (See also VIB1)
  177. Deep Fungus Infection (See also VD1)
  178. IIIE3 Irregular Epidermal Proliferation, Above A Neoplasm
  179. Verrucous Melanoma (See also VIB3)
  180. IIIF Superficial Dermatitis With Lichenoid Infiltrates (Lichenoid Dermatitis)
  181. IIIF1 Lichenoid Dermatitis, Lymphocytes Exclusively
  182. Lichen Planus
  183. Graft-Versus-Host Disease
  184. Mycosis Fungoides, Patch/Plaque Stage
  185. IIIF2 Lichenoid Dermatitis, Lymphocytes Predominant
  186. Lichen Planus–Like Keratosis (Benign Lichenoid Keratosis)
  187. IIIF2a Lichenoid Dermatitis, Eosinophils Present
  188. Lichenoid Drug Eruptions
  189. IIIF2b Lichenoid Dermatitis, Plasma Cells Present
  190. Lichenoid Actinic Keratosis
  191. Secondary Syphilis
  192. IIIF2c Lichenoid Dermatitis, With Melanophages
  193. IIIF3 Lichenoid Dermatitis, Histiocytes Predominant
  194. Lichen Nitidus
  195. IIIF4 Lichenoid Dermatitis, Mast Cells Predominant
  196. Urticaria Pigmentosa, Lichenoid Examples
  197. IIIF5 Lichenoid Dermatitis With Dermal Fibroplasia
  198. Mycosis Fungoides, Patch Stage
  199. IIIG Superficial Vasculitis and Vasculopathies
  200. IIIG1 Neutrophilic Vasculitis
  201. Cutaneous Necrotizing (Leukocytoclastic) Vasculitis
  202. Septic Vasculitis (Gonococcemia)
  203. IIIG2 Mixed Cell and Granulomatous Vasculitis
  204. Granuloma Faciale
  205. IIIG3 Vasculopathies With Lymphocytic Inflammation
  206. Pigmented Purpuric Dermatoses
  207. IIIG4 Vasculopathies With Scant Inflammation
  208. Stasis Dermatitis
  209. Stasis Dermatitis
  210. IIIG5 Thrombotic, Embolic and Other Microangiopathies
  211. Lupus Anticoagulant and Antiocardiolipin Syndromes
  212. Cryoglobulinemia
  213. IIIH Superficial Dermatitis With Interface Vacuoles (Interface Dermatitis)
  214. IIIH1 Vacuolar Dermatitis, Apoptotic/Necrotic Cells Prominent
  215. Erythema Multiforme
  216. Fixed Drug Eruption
  217. Graft-Versus-Host Disease, Acute
  218. IIIH2 Vacuolar Dermatitis, Apoptotic Cells Usually Absent
  219. Dermatomyositis
  220. IIIH3 Vacuolar Dermatitis, Variable Apoptosis
  221. Subacute Cutaneous Lupus Erythematosus
  222. IIIH4 Vacuolar Dermatitis, Basement Membranes Thickened
  223. Discoid Lupus Erythematosus
  224. References
  225. Acantholytic, Vesicular, and Pustular Disorders
  226. IVA Subcorneal and/or Intracorneal Separation
  227. IVA1 Sub/Intracorneal Separation, Scant Inflammatory Cells
  228. Pemphigus Foliaceus
  229. IVA2 Sub/Intracorneal Separation, Neutrophils Prominent
  230. Impetigo Contagiosa
  231. Staphylococcal Scalded Skin Syndrome
  232. Folliculitis With Subcorneal Pustule Formation
  233. Acute Generalized Exanthematous Pustulosis
  234. Pustular Psoriasis and Palmoplantar Pustulosis
  235. IVA3 Sub/Intracorneal Separation, Eosinophils Predominant
  236. Erythema Toxicum Neonatorum
  237. Scabies With Eosinophilic Pustulosis
  238. IVB Intraspinous Keratinocyte Separation, Spongiotic
  239. IVB1 Intraspinous Spongiosis, Scant Inflammatory Cells
  240. Friction Blister
  241. IVB2 Intraspinous Spongiosis, Lymphocytes Predominant
  242. Dyshidrotic Dermatitis/Eczema (Pompholyx)
  243. IVB2a Intraspinous Spongiosis, Eosinophils Present
  244. Acute Contact Dermatitis
  245. Bullous Pemphigoid, Urticarial Phase
  246. Incontinentia Pigmenti
  247. IVB3 Intraspinous Spongiosis, Neutrophils Predominant
  248. Dermatophytosis
  249. IVC Intraspinous Keratinocyte Separation, Acantholytic
  250. IVC1 Intraspinous Acantholysis, Scant Inflammatory Cells
  251. Familial Benign Pemphigus (Hailey–Hailey Disease)
  252. Transient Acantholytic Dermatosis (Grover Disease)
  253. IVC2 Intraspinous Acantholysis, Predominant Lymphocytes
  254. Herpes Simplex
  255. Varicella-Zoster Infection
  256. Toxic Epidermal Necrolysis, Stevens–Johnson Syndrome, and Erythema Multiforme With Intraepidermal Vesiculation
  257. Paraneoplastic Pemphigus
  258. IVC2a Intraspinous Acantholysis, Eosinophils Present
  259. Pemphigus Vegetans
  260. IVC3 Intraspinous Separation, Neutrophils or Mixed Cell types
  261. IgA Pemphigus
  262. IVD Suprabasal Keratinocyte Separation
  263. IVD1 Suprabasal Vesicles, Scant Inflammatory Cells
  264. Keratosis Follicularis (Darier Disease)
  265. Warty Dyskeratoma
  266. IVD2 Suprabasal Separation, Lymphocytes and Plasma Cells
  267. Acantholytic Actinic Keratosis
  268. IVD3 Suprabasal Vesicles, Lymphocytes and Eosinophils
  269. Pemphigus Vulgaris
  270. IVE Subepidermal Vesicular Dermatitis
  271. IVE1 Subepidermal Vesicles, Scant /No Inflammation
  272. Porphyria Cutanea Tarda and Other Porphyrias
  273. IVE2 Subepidermal Vesicles, Lymphocytes Predominant
  274. Bullous Lichen Planus
  275. Polymorphous (Polymorphic) Light Eruption
  276. Bullous Dermatophytosis
  277. Bullous Lichen Sclerosus et Atrophicus
  278. IVE3 Subepidermal Vesicles, Eosinophils Prominent
  279. Bullous Pemphigoid
  280. Bullous Drug Eruption
  281. Pemphigoid Gestationis (Herpes Gestationis)
  282. IVE4 Subepidermal Vesicles, Neutrophils Prominent
  283. Dermatitis Herpetiformis (Duhring Disease)
  284. Linear IgA Bullous Dermatosis
  285. Bullous Lupus Erythematosus
  286. Epidermolysis Bullosa Acquisita
  287. IVE5 Subepidermal Vesicles, Mast Cells Prominent
  288. Bullous Mastocytosis
  289. References
  290. Perivascular, Diffuse, and Granulomatous Infiltrates of the Reticular Dermis
  291. VA Superficial and Deep Perivascular Infiltrates Without Vasculitis
  292. VA1 Perivascular Infiltrates, Lymphocytes Predominant
  293. Erythema Annulare Centrifugum
  294. Erythema Chronicum Migrans
  295. Tumid Lupus Erythematosus
  296. VA2 Perivascular Infiltrates, Neutrophils Predominant
  297. Cellulitis
  298. VA3 Perivascular Infiltrates, Lymphocytes and Eosinophils
  299. Papular Urticaria
  300. Urticaria
  301. Pruritic Urticarial Papules and Plaques of Pregnancy
  302. VA4 Perivascular Infiltrates, With Plasma Cells
  303. Secondary Syphilis
  304. Tertiary Syphilis
  305. Morphea (See Description in VF)
  306. VA5 Perivascular Infiltrates, Mixed Cell Types
  307. Erythema Chronicum Migrans
  308. VB Vasculitis and Vasculopathies
  309. VB1 Vascular Damage, Scant Inflammatory Cells
  310. Degos Syndrome
  311. VB2 Vasculitis, Lymphocytes Predominant
  312. Pernio
  313. Pityriasis Lichenoides
  314. Cytomegalovirus Infection
  315. Erythema Chronicum Migrans
  316. VB3 Vasculitis, Neutrophils Prominent
  317. Polyarteritis Nodosa and Microscopic Polyangiitis
  318. Neutrophilic Small-Vessel Vasculitis (Leukocytoclastic Vasculitis)
  319. Erythema Elevatum Diutinum
  320. VB4 Vasculitis, Mixed Cell Types and/or Granulomas
  321. Eosinophilic Granulomatosis With Polyangiitis
  322. Papulonecrotic Tuberculid
  323. VB5 Thrombotic and Other Microangiopathies
  324. Calciphylaxis
  325. Livedo Reticularis
  326. VC Diffuse Infiltrates of the Reticular Dermis
  327. VC1 Diffuse Infiltrates, Lymphocytes Predominant
  328. Jessner Lymphocytic Infiltration of the Skin
  329. Leukemia Cutis
  330. VC2 Diffuse Infiltrates, Neutrophils Predominant
  331. Acute Febrile Neutrophilic Dermatosis (Sweet Syndrome)
  332. Neutrophilic Dermatosis of the Dorsal Hands
  333. Erysipelas
  334. VC3 Diffuse Infiltrates, “Histiocytoid” Cells Predominant
  335. Lepromatous Leprosy
  336. Langerhans Cell Histiocytosis (Histiocytosis X)
  337. Xanthelasma
  338. VC4 Diffuse Infiltrates, Plasma Cells Prominent
  339. Secondary Syphilis
  340. VC5 Diffuse Infiltrates, Mast Cells Predominant
  341. Urticaria Pigmentosa
  342. VC6 Diffuse Infiltrates, Eosinophils Predominant
  343. Eosinophilic Cellulitis (Wells Syndrome)
  344. Tick Bite
  345. VC7 Diffuse Infiltrates, Mixed Cell Types
  346. Cutaneous Leishmaniasis
  347. VC8 Diffuse Infiltrates, Pigment Cells
  348. Nevi of Ota and Ito and Dermal Melanocyte Hamartoma
  349. VC9 Diffuse Infiltrates, Extensive Necrosis
  350. Gangrenous Ischemic Necrosis
  351. VD Diffuse or Nodular Infiltrates of the Reticular Dermis With Epidermal Proliferation
  352. VD1 Epidermal Proliferation With Mixed Cellular Infiltrates
  353. North American Blastomycosis
  354. Deep Fungal Infections—General
  355. VE Nodular Inflammatory Infiltrates of the Reticular Dermis—Granulomas, Abscesses, and Ulcers
  356. VE1 Epithelioid Cell Granulomas Without Necrosis
  357. Sarcoidosis
  358. Lupus Vulgaris
  359. VE2 Epithelioid Cell Granulomas With Necrosis
  360. Tuberculosis
  361. Tuberculoid Leprosy
  362. Lupus Miliaris Disseminatus Facei
  363. VE3 Palisading Granulomas
  364. Granuloma Annulare
  365. Necrobiosis Lipoidica
  366. Necrobiotic Xanthogranuloma With Paraproteinemia
  367. Rheumatoid Nodules
  368. Palisaded Neutrophilic and Granulomatous Dermatitis
  369. VE4 Mixed Cell Granulomas
  370. Foreign-Body Reactions
  371. VE5 Inflammatory Nodules With Prominent Eosinophils
  372. Angiolymphoid Hyperplasia With Eosinophilia
  373. Epithelioid Hemangioma
  374. Kimura Disease
  375. Scabetic Nodule
  376. VE6 Inflammatory Nodules With Mixed Cell Types
  377. Sporotrichosis
  378. Atypical Mycobacteria
  379. VE7 Inflammatory Nodules With Necrosis and Neutrophils (Abscesses)
  380. Botryomycosis
  381. Chromoblastomycosis
  382. VE8 Inflammatory Nodules With Prominent Necrosis
  383. Aspergillosis
  384. VE9 Chronic Ulcers and Sinuses Involving the Reticular Dermis
  385. Chancroid
  386. Pyoderma Gangrenosum
  387. Chondrodermatitis Nodularis Helicis
  388. VF Dermal Matrix Fiber Disorders
  389. VF1 Fiber Disorders, Collagen Increased
  390. Scleroderma
  391. Radiation Dermatitis
  392. Nephrogenic Systemic Fibrosis
  393. Regressing Melanoma
  394. Superficial Scar (e.g., Biopsy Site Reaction)
  395. VF2 Fiber Disorders, Collagen Reduced
  396. Focal Dermal Hypoplasia (Goltz Syndrome)
  397. VF3 Fiber Disorders, Elastin Increased or Prominent
  398. Pseudoxanthoma Elasticum
  399. VF4 Fiber Disorders, Elastin Reduced
  400. Anetoderma (Macular Atrophy)
  401. VF5 Fiber Disorders, Perforating
  402. Elastosis Perforans Serpiginosa
  403. Reactive Perforating Collagenosis
  404. Perforating Folliculitis
  405. VG Deposition of Material in the Dermis
  406. VG1 Increased Normal Nonfibrous Matrix Constituents
  407. Digital Mucous Cysts and Cutaneous Focal Mucinosis
  408. Mucinosis in Lupus Erythematosus
  409. Mucinoses
  410. Pretibial Myxedema
  411. Scleredema
  412. Lichen Myxedematosus and Scleromyxedema
  413. VG2 Increased Material Not Normally Present in the Dermis
  414. Gout
  415. Oxalosis
  416. Colloid Milium
  417. Idiopathic Calcinosis Cutis
  418. Cryoglobulinemia
  419. Keratin Granuloma
  420. Suture Granuloma
  421. Minocycline Pigmentation
  422. VG3 Parasitic Infestations of the Dermis and/or Subcutis
  423. Cutaneous Larva Migrans
  424. References
  425. Tumors and Cysts of the Dermis and Subcutis
  426. VIA Small and Intermediate Cell Tumors
  427. VIA1 Tumors of Lymphocytes or Hemopoietic Cells
  428. Cutaneous B-Cell Follicle Center Lymphoma
  429. Cutaneous Diffuse B-Cell Lymphoma
  430. Primary Cutaneous Marginal Zone (MALT) Lymphoma
  431. Cutaneous T-Cell Lymphoma, Tumor Stage
  432. VIA2 Tumors of Lymphocytes and Mixed Cell Types
  433. B-Cell Cutaneous Lymphoid Hyperplasia (B-CLH, Pseudolymphoma, Lymphocytoma Cutis)
  434. VIA3 Tumors of Plasma Cells
  435. Cutaneous Plasmacytoma and Multiple Myeloma (MM)
  436. VIA4 Small Round Cell Tumors
  437. Cutaneous Small Cell Undifferentiated Carcinoma (Merkel Cell Tumor)
  438. Metastatic Small Cell Carcinoma
  439. VIB Large Polygonal and Round Cell Tumors
  440. VIB1 Squamous Cell Tumors
  441. Squamous Cell Carcinoma
  442. Keratoacanthoma
  443. Inverted Follicular Keratosis
  444. Pseudoepitheliomatous Hyperplasia (PEH)
  445. Proliferating Trichilemmal Cyst (Pilar Tumor)
  446. Prurigo Nodularis
  447. VIB2 Adenocarcinomas
  448. Metastatic Adenocarcinoma
  449. Metastatic Mammary Ductal Carcinoma
  450. Mammary Carcinoma, “Inflammatory” Type
  451. VIB3 Melanocytic Tumors
  452. VIB3a Melanocytic Lesions With Little or No Cytologic Atypia
  453. Melanocytic Nevi, Acquired and Congenital Types
  454. Acquired Nevi, Compound and Dermal
  455. Balloon Cell Nevus
  456. Halo Nevus
  457. Acral Nevus
  458. Congenital Nevus
  459. Blue Nevus
  460. Cellular Blue Nevus
  461. VIB3b Melanocytic Lesions With Cytologic Atypia
  462. Deep Penetrating Nevus
  463. Spitz Tumor/Nevus
  464. Nodular Melanoma
  465. Superficial Spreading Melanoma (Tumorigenic)
  466. Nevoid Melanoma
  467. Metastatic Malignant Melanoma
  468. Metastatic Malignant Melanoma, Satellite Lesion
  469. Epidermotropic Metastatic Melanoma
  470. Pigmented Epithelioid Melanocytoma (PEM)/Epithelioid Blue Nevus
  471. Melanocytic Tumor of Uncertain Malignant Potential
  472. VIB4 Eccrine Tumors
  473. VIB4a Circumscribed, Symmetrical Eccrine Tumors
  474. Eccrine Spiradenoma
  475. Cylindroma
  476. Poroma
  477. Syringoma
  478. Nodular Hidradenoma
  479. Clear Cell Syringoma
  480. Mixed Tumor (Chondroid Syringoma)
  481. VIB4b Infiltrative, Asymmetrical Eccrine Tumors
  482. Microcystic Adnexal Carcinoma
  483. Mucinous Carcinoma (Mucinous Eccrine Carcinoma)
  484. Digital Papillary Adenocarcinoma
  485. VIB5 Apocrine Tumors
  486. Tubular Apocrine Adenoma
  487. Syringocystadenoma Papilliferum
  488. VIB6 Pilar Tumors
  489. Trichoepithelioma
  490. Desmoplastic Trichoepithelioma
  491. Dilated Pore of Winer
  492. Pilar Sheath Acanthoma
  493. Trichilemmoma
  494. Trichofolliculoma
  495. Fibrofolliculoma/Trichodiscoma
  496. Trichoadenoma
  497. Pilomatricoma
  498. Trichoblastoma
  499. VIB7 Sebaceous Tumors
  500. Sebaceous Adenoma and Sebaceous Epithelioma (Sebaceoma)
  501. Sebaceous Hyperplasia
  502. Nevus Sebaceus of Jadassohn
  503. Sebaceous Epithelioma
  504. Sebaceous Carcinoma
  505. VIB8 “Histiocytoid” and Miscellaneous Clear Cell Tumors
  506. Xanthomas and Xanthelasma
  507. Xanthelasma
  508. Eruptive Xanthoma
  509. Verruciform Xanthoma
  510. Juvenile Xanthogranuloma (JXG)
  511. Reticulohistiocytosis
  512. Metastatic Renal Cell Carcinoma
  513. VIB9 Tumors of Large Hematolymphoid Cells
  514. Cutaneous CD30+ (Ki-1+) Anaplastic Large Cell Lymphoma (ALCL)
  515. Lymphomatoid Papulosis
  516. Leukemia Cutis
  517. Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type
  518. VIB10 Mast Cell Tumors
  519. Urticaria Pigmentosa, Nodular Lesions (See also IIIA.2)
  520. VIB11 Tumors With Prominent Necrosis
  521. Epithelioid Sarcoma
  522. VIB12 Miscellaneous and Undifferentiated Epithelial Tumors
  523. Granular Cell Tumor
  524. Cellular Neurothekeoma
  525. Metastatic Malignant Melanoma
  526. VIC Spindle Cell, Pleomorphic, and Connective Tissue Tumors
  527. VIC1 Fibrohistiocytic Spindle Cell Tumors
  528. VIC1a Fibrohistiocytic Tumors With Minimal or No Atypia
  529. Dermatofibroma
  530. Cellular Dermatofibroma
  531. Sclerosing/Angiomatoid Spitz Nevus (Desmoplastic Spitz Nevus)
  532. Dermatofibrosarcoma Protuberans
  533. Fibrous Papule (Angiofibroma)
  534. Recurrent Infantile Digital Fibromatosis
  535. Keloid
  536. Acquired Digital Fibrokeratoma
  537. Tenosynovial Giant Cell Tumor (Giant Cell Tumor of Tendon Sheath)
  538. Nodular Fasciitis
  539. VIC1b Fibrohistiocytic Tumors With High-Grade Atypia
  540. Atypical Fibroxanthoma
  541. Malignant Fibrous Histiocytoma (Pleomorphic Dermal Sarcoma)
  542. Dermatofibrosarcoma Protuberans With Sarcomatoid Change
  543. VIC1c Lesions With Myxoid Changes
  544. Mucocele
  545. Digital Mucous Cyst
  546. Cutaneous Myxoma
  547. VIC2 Schwannian/Neural Spindle Cell Tumors
  548. Neurofibromas
  549. Neurofibromatosis
  550. Schwannoma (Neurilemmoma)
  551. Palisaded Encapsulated Neuroma
  552. Accessory Digit
  553. VIC3 Spindle Cell Tumors of Muscle
  554. Leiomyomas
  555. Smooth Muscle Hamartoma
  556. Leiomyosarcoma
  557. VIC4 Melanocytic Spindle Cell Tumors
  558. Desmoplastic Melanoma
  559. VIC5 Tumors and Proliferations of Angiogenic Cells
  560. Pyogenic Granuloma (Lobular Capillary Hemangioma)
  561. Intravascular Papillary Endothelial Hyperplasia (Masson’s Hemangioendotheliome Vegetant Intravasculaire)
  562. Stasis Dermatitis With Vascular Proliferation (Acroangiodermatitis, Pseudo-Kaposi Sarcoma)
  563. Kaposi Sarcoma
  564. Diffuse Dermal Angiomatosis
  565. Cutaneous Angiosarcoma
  566. Cutaneous Epithelioid Angiomatous Nodule/Epithelioid Hemangioendothelioma
  567. Targetoid Hemosiderotic Hemangioma (Hobnail Hemangioma)
  568. Angiokeratoma
  569. Arteriovenous Hemangioma
  570. Cavernous Hemangioma
  571. Cherry Hemangioma
  572. Microvenular Hemangioma
  573. Cutaneous Lymphangioma
  574. Venous Lake
  575. Glomangioma
  576. Glomus Tumor
  577. VIC6 Tumors of Adipose Tissue
  578. Nevus Lipomatosus Superficialis
  579. Lipoma
  580. Angiolipoma
  581. Spindle Cell Lipoma
  582. Pleomorphic Lipoma
  583. Liposarcoma
  584. VIC7 Tumors of Cartilaginous Tissue
  585. VIC8 Tumors of Osseous Tissue
  586. Albright’s Hereditary Osteodystrophy and Osteoma Cutis
  587. IVD Cysts of the Dermis and Subcutis
  588. VID1 Pilar Differentiation
  589. Epidermal or Infundibular Cyst
  590. Trichilemmal (Pilar) Cyst
  591. Steatocystoma
  592. Vellus Hair Cyst
  593. VID2 Eccrine and Similar Differentiation
  594. Eccrine Hidrocystoma
  595. Median Raphe Cyst
  596. Bronchogenic Cyst
  597. Cutaneous Endometriosis
  598. VID3 Apocrine Differentiation
  599. Apocrine Hidrocystoma
  600. Hidradenoma Papilliferum
  601. References
  602. Inflammatory and Other Disorders of Skin Appendages
  603. VIIA Pathology Involving Hair Follicles
  604. VIIA1 Scant Inflammation
  605. Androgenetic Alopecia
  606. Trichotillomania
  607. Telogen Effluvium
  608. Keratosis Pilaris
  609. Scurvy
  610. VIIA2 Lymphocytes Predominant
  611. Alopecia Areata
  612. Lichen Planopilaris
  613. Central Centrifugal Cicatricial Alopecia
  614. Discoid Lupus Erythematosus of the Scalp
  615. Follicular Mucinosis and Alopecia Mucinosa
  616. Rosacea
  617. VIIA3 With Prominent Eosinophils
  618. Eosinophilic Pustular Folliculitis
  619. VIIA4 Neutrophils Prominent
  620. Acute Deep Folliculitis (Furuncle)
  621. Tinea Capitis
  622. Majocchi Granuloma
  623. Herpes Simplex Viral Folliculitis
  624. VIIA5 Plasma Cells Prominent
  625. Folliculitis (Acne) Keloidalis Nuchae
  626. Tinea Capitis
  627. VIIA6 Fibrosing and Suppurative Follicular Disorders
  628. Follicular Occlusion Triad (Hidradenitis Suppurativa, Acne Conglobata, and Perifolliculitis Capitis Abscedens et Suffodiens)
  629. Hidradenitis Suppurativa
  630. Dissecting Cellulitis of the Scalp
  631. Folliculitis Decalvans
  632. VIIB Pathology Involving Sweat Glands
  633. VIIB1 Scant Inflammation
  634. Eccrine Nevus
  635. VIIB2 Lymphocytes Predominant
  636. Lichen Striatus
  637. VIIB2a With Plasma Cells
  638. Lupus Erythematosus
  639. VIIB2b With Eosinophils
  640. Arthropod Assault Reaction
  641. VIIB2c Neutrophils Predominant
  642. Neutrophilic Eccrine Hidradenitis
  643. Idiopathic Recurrent Palmoplantar Hidradenitis
  644. VIIC Pathology Involving Nerves
  645. VIIC1 Lymphocytic Infiltrates
  646. VIIC2 Mixed Inflammatory Infiltrates
  647. Nerve Involvement in Leprosy
  648. Erythema Chronicum Migrans With Nerve Involvement
  649. Arthropod Bite Reaction With Nerve Involvement
  650. VIIC3 Neoplastic Infiltrates
  651. Neurotropic Melanoma
  652. VIID Pathology of the Nails
  653. VIID1 Lymphocytic Infiltrates
  654. Acral Lentiginous Melanoma
  655. VIID2 Lymphocytes With Neutrophils
  656. Onychomycosis
  657. VIID3 Vesiculobullous Diseases
  658. Darier Disease
  659. VIID4 Parasitic Infestations
  660. Scabies
  661. References
  662. Disorders of the Subcutis
  663. VIIIA Subcutaneous Vasculitis and Vasculopathy (Septal or Lobular)
  664. VIIIA1 Neutrophilic Vasculitis
  665. Cutaneous/Subcutaneous Polyarteritis Nodosa (See also Section VB3 and Table VIII.1)
  666. VIIIA2 Lymphocytic “Vasculitis”
  667. VIIIA3 Granulomatous “Vasculitis”
  668. Erythema Induratum (Nodular Vasculitis)
  669. VIIIB Septal Panniculitis Without Vasculitis
  670. VIIIB1 Septal Panniculitis, Lymphocytes and Mixed Infiltrates
  671. Erythema Nodosum
  672. VIIIB2 Septal Panniculitis, Granulomatous
  673. Subcutaneous Granuloma Annulare
  674. VIIIB3 Septal Panniculitis, Sclerotic
  675. Scleroderma and Morphea
  676. VIIIC Lobular Panniculitis Without Vasculitis
  677. VIIIC1 Lobular Panniculitis, Lymphocytes Predominant
  678. Lupus Erythematosus Panniculitis
  679. VIIIC2 Lobular Panniculitis, Lymphocytes and Plasma Cells
  680. VIIIC3 Lobular Panniculitis, Neutrophilic
  681. VIIIC4 Lobular Panniculitis, Eosinophils Prominent
  682. VIIIC5 Lobular Panniculitis, Histiocytes Prominent
  683. Cytophagic Histiocytic Panniculitis
  684. VIIIC6 Lobular Panniculitis, Mixed With Foam Cells
  685. Relapsing Febrile Nodular Nonsuppurative Panniculitis
  686. VIIIC7 Lobular Panniculitis, Granulomatous
  687. Subcutaneous Sarcoidosis
  688. VIIIC8 Lobular Panniculitis, Crystal Deposits, Calcifications
  689. Subcutaneous Fat Necrosis of the Newborn
  690. Calcifying Panniculitis (Calciphylaxis)
  691. VIIIC9 Lobular Panniculitis, Necrosis Prominent
  692. Subcutaneous Nodular Fat Necrosis in Pancreatic Disease
  693. VIIIC10 Lobular Panniculitis, Embryonic Fat Pattern
  694. Localized Lipoatrophy and Lipodystrophy
  695. VIIIC11 Lobular Panniculitis, Lipomembranous
  696. Lipomembranous Change or Lipomembranous Panniculitis
  697. VIIID Mixed Lobular and Septal Panniculitis
  698. VIIID1 With Hemorrhage or Sclerosis
  699. Panniculitis due to Physical or Chemical Agents
  700. VIIID2 With Many Neutrophils
  701. Necrotizing Fasciitis
  702. Alpha-1-Antitrypsin Deficiency–Associated Panniculitis
  703. VIIID3 With Many Eosinophils
  704. Eosinophilic Fasciitis (Shulman Syndrome)
  705. VIIID4 With Many Lymphocytes
  706. Subcutaneous Panniculitis-Like T-Cell Lymphoma
  707. VIIID5 With Cytophagic Histiocytes
  708. Sinus Histiocytosis With Massive Lymphadenopathy (SHML, Rosai–Dorfman)
  709. VIIID6 With Granulomas
  710. Mycobacterial Panniculitis
  711. Erythema Nodosum Leprosum (Type 2 Leprosy Reaction)
  712. VIIIE Subcutaneous Abscesses
  713. VIIIE1 With Neutrophils
  714. Phaeohyphomycotic Cyst
  715. References
  716. Index
Escribir Su propia reseña
Va a opinar sobre:Atlas Of Dermatopathology Synopsis And Atlas Of Lever'S Histopathology Of The Skin 4Ed

Productos relacionados